Seoul, South Korea

Tae Gyu Lee

This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: Hyundai Motor Company, Kia Corporation, Kookmin University Industry Academy Cooperation Foundation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tae Gyu Lee. Retrieved from https://idiyas.com/inventor/tae-gyu-lee-ba3dp74y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 50.0

Average Co-Inventor Count = 5.6

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Tae Gyu Lee

Introduction

Tae Gyu Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibody variants.

Latest Patents

One of his key patents is titled "Antibody Fc Variants for Increased Blood Half-Life." This innovation aims to enhance the therapeutic efficacy of antibodies by prolonging their presence in the bloodstream.

Career Highlights

Throughout his career, Tae Gyu Lee has worked with esteemed organizations such as the Osong Medical Innovation Foundation and the Kookmin University Industry Academy Cooperation Foundation. His work in these institutions has allowed him to advance his research and contribute to the medical field.

Collaborations

He has collaborated with notable colleagues, including Soo Han Lee and Su Kim, to further his research and innovations.

Conclusion

Tae Gyu Lee's contributions to biotechnology, particularly through his patent on antibody variants, highlight his role as an influential inventor in the field. His work continues to impact medical research and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…